StonvexLoading…
StonvexStonvexStonvexCore line items from VIVK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $104.42M | $89.81M | $59.32M | $28.11M |
Operating Income | $-63.83M | $-22.00M | $-6.33M | $-22.74M |
Net Income | $-110.24M | $-26.35M | $-10.84M | $-20.25M |
EPS (Diluted) | $-318.01 | $-151.32 | $-0.56 | Not available |
Total Assets | $113.49M | $241.04M | $71.24M | $76.34M |
Total Liabilities | $76.30M | $125.92M | $54.00M | $49.28M |
Cash & Equivalents | $265.02K | $651.02K | $744.31K | $3.10M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-4.09M | $-6.63M |
Shares Outstanding | 2.01M | 208.55K | 26.22M | 18.06M |